RapTr2022, Aragen Bioscience’s CLD-services platform, includes the proven CHO-DG44 and CHO-GS cell lines and proprietary vector combinations with an innovative clone-selection process (Fig.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback